期刊文献+

雄激素受体与男性代谢综合征 被引量:1

Androgen receptor and metabolic syndrome in men
原文传递
导出
摘要 雄激素受体(androgen receptor,AR)属于核受体超家族成员,以配体依赖的方式介导靶基因的转录活性,并招募一系列辅调节因子调控其转录,发挥其生物学功能。近年研究证实,AR可作为一个正向调节因子,通过影响脂代谢、抑制前脂肪细胞的转化、增强机体对胰岛素的敏感性等途径有效预防肥胖和胰岛素抵抗相关疾病的发生。对AR的结构、作用机制及其对男性脂代谢、胰岛素抵抗等影响的研究进展进行综述。 Androgen receptor (AR) is a member of nuclear receptor superfamily and induces transactivation of target genes in a ligand-dependent manner. In this process, AR recruits a series of co-regulators to modulate AR-mediated transactivation and exerts its biological functions. Recent studies clarified that AR, acting as a positive regulatory factor, plays significant roles in influencing lipid metabolism, inhibiting conversion of pre-adipocytes and enhancing insulin sensitivity. AR might be a drug target to prevent the diseases which are relative to obesity, insulin resistance, and so on. We review the recent advances on AR structure, mechanism of AR-induced transactivation of target genes, and its biological functions in lipid metabolism and insulin resistance in man.
作者 邓仕超 赵越
机构地区 中国医科大学
出处 《生命的化学》 CAS CSCD 2013年第1期41-45,共5页 Chemistry of Life
基金 国家自然科学基金项目(30871390 31171259 31271364) 国家重大科学研究计划("973"计划)(2013CB945200)
关键词 雄激素受体 转录调控 脂代谢异常 肥胖 胰岛素抵抗 androgen receptor modulation of transactivation abnormal lipid metabolism obesity insulin resistance
  • 相关文献

参考文献25

  • 1Mauvais-Jarvis F. Estrogen and androgen receptors: regulators of fuel homeostasis and emerging targets for diabetes and obesity. Trends Endocrinol Metab, 2010, 22: 24-33.
  • 2Helsen C, Dubois V, Verfaillie A, et al. Evidence for DNA-binding domain--ligand-binding domain communications in the androgen receptor. Mol Cell Biol, 2012, 32:3033-3043.
  • 3Wilson EM. Analysis of interdomain interactions of the androgen receptor. Methods Mol Biol, 2011, 776:113- 129.
  • 4Zhao Y, Goto K, Saitoh M, et al. Activation function-1 domain of androgen receptor contributes to the interaction between subnuclear splicing factor compartment and nuclear receptor compartment. J Biol Chem, 2002, 33: 30031-30039.
  • 5Saad F, Aversa A, Isidori AM, et al. Testosterone as potential effective therapy in treatment of obesity in men with testosteronedeficiency: a review. Curt Diabetes Rev, 2012, 8:131-143.
  • 6Zitzmann M, Faber S, Nieschlag E, et al. Association of specific symptoms and metabolic risks with serumtestosterone in older men. J Clin Endocrinol Metab, 2006, 91:4335-4343.
  • 7Bojesen A, Kristensen K, Birkebaek NH, et al. The metabolic syndrome is frequent in Klinefelter's syndrome and is associated with abdominal obesity and hypogonadism. Diabetes Care, 2006, 29:1591-1598.
  • 8Basaria S, Muller DC, Carducci MA, et al. Hyperglycemia and insulin resistance in men with prostate carcinoma who receive androgen-deprivation therapy. Cancer, 2006, 106:581-588.
  • 9Rana K, Fam BC, Clarke MV, et al. Increased adiposity in DNA binding-dependent androgen receptor knockout male mice associated with decreased voluntary activity and not insulin resistance. Am J Physiol Endocrinol Metab, 2011, 301:E767-E778.
  • 10Matsumoto T, Shiina H, Kawano H, et al. Androgen receptor functions in male and female physiology. J Steroid Biochem Mol Biol, 2008, 109:236-241.

同被引文献11

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部